Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
OA02 - Novel Therapies in ROS1, HER2 and EGFR
- 10:30 - 12:00
- 9/24/2018
- Location: Room 105
- Type: Oral Abstract Session
- Track: Targeted Therapy
-
+
OA02.08 - Discussant - OA 02.05, OA 02.06, OA 02.07
11:45 - 12:00 | Presenter: Daniel B Costa
- Abstract
No abstract available for this presentation
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.13-44 - Safety, PK, and Preliminary Antitumor Activity of the Oral EGFR/HER2 Exon 20 Inhibitor TAK-788 in NSCLC
16:45 - 18:00 | Presenter: Joel W. Neal | Author(s): Robert C. Doebele, Gregory J Riely, Alexander Spira, Leora Horn, Zofia Piotrowska, Daniel B Costa, Steven Zhang, Dean Bottino, Jian Zhu, David Kerstein, Shuanglian Li, Pasi A Jänne
- Abstract
Loading...
-
+
MA15 - Colliding Approaches - EGFR and Immunotherapy
- 13:30 - 15:00
- 9/25/2018
- Location: Room 107
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
-
+
MA15.02 - Long-Term Safety and Clinical Activity Results from a Phase Ib Study of Erlotinib Plus Atezolizumab in Advanced NSCLC
13:35 - 13:40 | Presenter: Charles M. Rudin | Author(s): Andres Cervantes, Afshin Dowlati, Benjamin Besse, Brigette Ma, Daniel B Costa, Peter Schmid, Rebecca Heist, Victoria M. Villaflor, Indrani Sarkar, Genevive Hernandez, Paul Foster, Jessica Spahn, Carol O'Hear, Scott N. Gettinger
- Abstract
Loading...